Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,446.95INR
6:18am EDT
Change (% chg)

Rs-7.40 (-0.51%)
Prev Close
Rs1,454.35
Open
Rs1,457.00
Day's High
Rs1,457.00
Day's Low
Rs1,445.00
Volume
1,258,490
Avg. Vol
846,947
52-wk High
Rs1,750.00
52-wk Low
Rs1,382.60

Latest Key Developments (Source: Significant Developments)

Lupin launches generic Epzicom tablets in U.S.
Wednesday, 29 Mar 2017 03:11am EDT 

Lupin Ltd : Says Lupin launches generic Epzicom tablets in the U.S. . Says drug indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection .Lupin's Abacavir and Lamivudine tablets, 600 mg/300 mg are ab rated generic equivalent of Viiv Healthcare Company's Epzicom tablets, 600 mg/300 mg..  Full Article

Lupin launches its pain drug in the U.S.
Wednesday, 8 Mar 2017 11:56pm EST 

Lupin Ltd : Says Lupin launches hydrocodone bitartrate and acetaminophen tablets in the U.S. .Says drug used for the relief of moderate to moderately severe pain.  Full Article

Lupin launches generic drug to treat major depressive disorder
Tuesday, 7 Mar 2017 01:06am EST 

Lupin Ltd : Says Lupin launches generic Paxil CR tablets in the U.S. .Drug indicated to treat major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.  Full Article

Lupin announces U.S. launch of generic drug to treat depression
Thursday, 2 Mar 2017 01:46am EST 

Lupin Ltd : Says Lupin launches generic Pristiq tablets in the U.S. .Says tablets are indicated for the treatment of major depressive disorder.  Full Article

Lupin receives USFDA approval for pain relievers
Tuesday, 28 Feb 2017 01:07am EST 

Lupin Ltd : Received final approval for its Oxycodone and Acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from USFDA . Says Lupin shall commence promoting the product shortly .Oxycodone and Acetaminophen tablets USP, are indicated for relief of moderate to moderately severe pain.  Full Article

Lupin's unit Kyowa and Astellas enter into agreement
Monday, 27 Feb 2017 01:17am EST 

Lupin Ltd : Says Astellas and Lupin s subsidiary Kyowa enter into an agreement . Says deal gives Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan .When astellas gets approval for new drug application of extended-release tablets of quetiapine fumarate, Kyowa will exclusively distribute products in Japan.  Full Article

Lupin gets FDA nod for generic version of Bayer Healthcare's antibiotic drug
Thursday, 16 Feb 2017 05:01am EST 

Lupin Ltd :Says gets final fda nod for moxifloxacin hydrochloride tablets.  Full Article

Lupin gets FDA nod for hydrocodone bitartrate and homatropine methylbromide syrup
Thursday, 16 Feb 2017 04:58am EST 

Lupin Ltd :Says received USFDA approval for ANDA hydrocodone bitartrate and homatropine methylbromide oral solution (syrup).  Full Article

Lupin Dec-qtr consol profit up about 21 pct
Thursday, 9 Feb 2017 02:59am EST 

Lupin Ltd : Dec quarter consol net profit 6.33 billion rupees . Dec quarter consol total income from operations 44.83 billion rupees . Consol net profit in Dec quarter last year was 5.25 billion rupees as per Ind-AS; consol total income from operations was 35.48 billion rupees .Consensus forecast for Dec quarter consol profit was 6.29 billion rupees.  Full Article

Lupin receives FDA approval for generic Paxil CR tablets
Monday, 23 Jan 2017 12:48am EST 

Lupin Ltd : "Lupin receives FDA approval for generic Paxil CR tablets" . Says Lupin shall commence promoting the product shortly .Drug used for treatment of major depressive disorder, panic disorder.  Full Article

More From Around the Web

BRIEF-Lupin launches generic Epzicom tablets in U.S.

* Says drug indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection